Alan Ebringer doktorearen lanak

ESPONDILITISAREN kontrako borrokan bide berria ireki du Alan Ebringer mediku eta immunologoak, 1976an lehenbizikoz planteatu zuenetik gure gaitzaren eta Klebsiella Pneumoniae bakterioaren arteko lotura. Espondilitisaren inguruan ikertu dituenez gain, beste gaixotasunetan ere ikerketa garrantzizkoak burutu ditu. Lan guzti horien bilduma osatzen ahalegindu gara hemen, Ebringerren lanaz ARGIA astekarian eta munduko prentsan plazaratu diren artikulu batzuekin batera. Ebringerrek eta bere lankideek publikatutako dokumentu andana Interneten irakur daiteke osorik, eta horien erreferentziak ipini ditugu hasierako ataletan. Orri honen beheko aldean, Alan Ebringerren bibliografia osoa eskaintzen dugu.

1. Espondilitisaren inguruan osorik irakur daitezkeenak:
- Alan Ebringerren hitzaldia Espondilitisaz eta Klebsiellaz Texaseko San Antonion 2000n,. Izorrategi honen atal berezi batean bilduta.
- ARGIA astekarian (2.106 zenbakia, 2007-10-14koa) gai honetaz plazaratutako artikulua: "Alan Ebringer, doktore gogaikarria (eta 2). Espondilitisaren kontrako terapia merkeegia aurkitu zuen medikua".
- Gaztelaniaz gune honetan bertan, Carol Sinclair-en "The IBS-Low Starch Diet" liburuari Ebringerrek egindako hitzaurrea eta horren ondoren John Merchantek Ebrigerren ideiak bilduz idatzitako "Manual de dieta de la Espondilitis Anquilosante".
- Frantsesez, Manu izeneko lagunak itzulita, Spondylarthrite-Alimentation gunean "La Spondylarthrite ankylosante est causée par le Klebsiella".
- Ingelesez Kickas guneak eskaintzen ditu honakoak:
-- Association of inflammation with elevated serum IgA in ankylosing spondylitis (1980).
-- Etiopathogenesis of ankylosing spondylitis and the crosstolerance hypothesis (1985).
-- Ankylosing spondylitis is caused by Klebsiella: Evidence from immunogenetic, microbiologic and serologic studies (1992).
-- Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae.
-- Molecular mimicry: The geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy (1996).
-- The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis (1996).
-- Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis (1997).
-- "Espondilitis Ankilopoietikoa, HLA-B27 eta Klebsiella - Ikuspegi orokorra: diagnostiko eta tratamendu goiztiar baterako proposamena":Ankylosing Spondylitis, HLS B27 and Klebsiella - An Overview: Proposal for early diagnosis and Treatment (PDF). 2006an "Current Rheumatology Reviews"en argitaratua. Ebringerrek Espondilitisaz orain artean publikatu duen azkena, eta aurrera begirako urrats berriak planteatzen dituena. Word formatuan ere bada.

2.- Behien Entzefalopatia Espongiformeaz, Esklerosi Anizkoitzaz eta Scrapiez Alan Ebringerrek egindako ikerketak garrantzizkoak izan dira. Behi Eroen Gaixotasuna deituaren kasuan, zientzilari gehienen artean nagusitu den teorian -"prioi" delakoan- oinarritu dira orain artean agintariak eta horrek eraman zituen XX. mende bukaeran Britainia Handian ia bost milioi behi eta zekor akabatzera. Ebringerrek teoria alternatibo bat proposatzen du: BEE gaixotasun immunologikoa dela, Acinetobacter bakterioak piztuarazia, ez dela kutsakorra eta behiak gaixorik daudenez jakiteko akabatu aurretik erabiltzeko testa egitea posible dela. Ildo honi segituz gero behi hilketa masiboa oker handi bat izan zen. Gaia eta horrek Britainia Handian sortutako polemika kontatu dira ARGIA astekariko erreportaje batean. Bestalde, Ebringerren teoriak ikerketa lerro berriak irekitzen ditu Esklerosi Anizkoitza eta Scrapie ulertu eta artatzeari dagokionez.

Guk honako erreferentziak eskaintzen ditugu Ebringerren lanaren atal honetatik:
- ARGIA astekarian (2.105 zenbakia, 2007-10-07koa) Behi Eroen Gaixotasuna dela eta Ebringerrek egindako ikertei buruzko erreportajea: Alan Ebringer, doktore gogaikarria (1). Eta milioika behi alferrik hil badituzte?
- Alan Ebringerrek Behi Eroen Gaixotasunaz egindako ikerketez Britainia Handiko batzorde bereziari eskainitako informearen laburpena. Honen jatorrizko bertsioa ingelesez hemen irakur daiteke.
- Behi Eroen Gaixotasunaz Ebringerrek proposatutakoez munduko prentsan publikatu diren artikulu batzuen erreferentzia eta laburpena.

Alan Ebringerren Bibliografia osoa

Alan Ebringer doktoreak hiru hamarkadaz aldizkari zientifikoetan publikatu dituenak bildu ditugu zerrenda honetan, aurretik ezagutzen genuen zerrendari gehituz medikuak berak eskuratu dizkigun azken dokumentuak. Artikuluak zerrendatu ditugu zaharrenetik berrienera eta gaixotasun nagusiotan sailkatuta:
- Espondilitis Ankilopoietikoa.
- Artriitis Erreumatoidea.
- Crohn gaixotasuna.
- Behien Entzefalopatia Espongiformeak, Creutzfeldt-Jakob Gaixotasunak, Esklerosi Anizkoitzak eta Scrapiek osatzen duten multzoa.

I.- Espondilitis Ankilopoietikoaz
. 1. Crossreactivity between Klebsiella aerogenes species and B27 lymphocyte antigens as an aetiological factor in ankylosing spondylitis. A. Ebringer, P. Cowling, N. Ngwa Suh, D.C.O. James and R.W. Ebringer. "HLA and Disease" Ed. Dausset and Svejgaard. Editions INSERM. 1976; 58:27 (HLA-B27 eta Klebsiella lehendabiziko aldiz lotzen dituen idatzia)
. 2. Ankylosing spondylitis: Klebsiella and HLA-27. R.W.Ebringer, D. Cook, D.R. Cawdell, P. Cowling and A. Ebringer. Rheumatology and Rehabilitation. 1977; 16: 190-196. (Espondilitisa duten gaixoen kakatan Klebsiella kopurua handiagoa dela lehenbizikoz erakusten duen idatzia).
. 3. Sequential studies in ankylosing spondylitis: Association of Klebsiella pneumoniae with active disease. R.W, Ebringer, D.R. Cawdell, P. Cowling and A. Ebringer. Annals of the Rheumatic Diseases 1978; 37: 146 - 151.
. 4. Immune response inversion following hyperimmunisation: A possible mechanism in the pathogenesis of HLA linked diseases. C.R. Young, A. Ebringer and J. Archer. Annals of the Rheumatic Diseases. 1978; 37: 152 - 158.
. 5. The link between genes and disease. A. Ebringer. New Scientist, 1978, 79: 865 -867.
. 6. Klebsiella pneumoniae and acute anterior uveitis in ankylosing spondylitis. R.W. Ebringer, D.Cawdell and A. Ebringer. British Medical Journal. 1979, 1: 383.
. 7. Ankylosing spondylitis, immune response genes and molecular. Mimicry. A. Ebringer. Lancet, 1979, I: 1186.
. 8. Ankylosing spondylitis, HLA-B27 and Klebsiella. I. Crossreactivity studies with rabbit antisera. J. Welsh, H. Avakian, P. Cowling, A. Ebringer, P. Wooley, G. Panayi and R.Ebringer. British Journal of Experimental Pathology, 1980, 61: 85 - 91.
. 9. Ankylosing spondylitis, HLA-B27 and Klebsiella. II. Crossreactivity studies with human tissue typing sera. H. Avakian, J. Welsh, A. Ebringer and C. Entwistle. British Journal of Experimental Pathology, 1980; 61: 92 - 96. (Anti-HLA-B27 motako antigorputzak eta Klebsiella lehenbizikoz lotu dituen idatzia).
. 10. C-reactive protein, erythrocyte sedimentation rate and Klebsiella in ankylosing spondylitis.
P. Cowling, R. Ebringer, D. Cawdell, M. Ishii and A. Ebringer. Annals of the Rheumatic Diseases, 1980; 39: 45 - 49.
. 11. Association of inflammation with elevated serum IgA in ankylosing spondylitis. (Kickasen). P. Cowling, R. Ebringer and A. Ebringer. Annals of the Rheumatic Diseases, 1980; 39: 545 - 549.
. 12. Ankylosing spondylitis: Host-parasite interaction in the production of rheumatological disease.
R. Ebringer and A. Ebringer. Recent Advances of Rheumatology. Edited by W. Watson Buchanan and W. Carson Dick, Churchill Livingstone. Edinburgh, 1981; 2: 107 - 120.
. 13. Uveitis, vitreous humour and Klebsiella. I. Binding studies with rabbit antisera. H. Avakian, R. Abuknesha, J. Welsh and A. Ebringer. British Journal of Opthalmology, 1981; 65: 315 - 322.
. 14. Uveitis, vitreous humour and Klebsiella. II. Crossreactivity studies using radioimmunoassay.
J Welsh, H. Avakian and A. Ebringer. British Journal of Opthalmology, 1981; 65: 323 - 328.
. 15. Spondylitis ankylopoietica und Klebsiella: Ein genetischer Zusammenhang. A. Ebringer.
Munchener Medizinische Wochenschrift, 1982; 124: 120 - 122.
. 16. The crosstolerance hypothesis in IR-gene systems, rheumatic fever and ankylosing spondylitis. A. Ebringer. Rivista di Biologia, 1982; 75: 197 - 229.
. 17. Yersinia enterocolitica biotype I, diarrhoea and episodes of HLA-B27 related ocular and rheumatic inflammatory disease in South-East England. R. Ebringer, D. Colthorpe, G. Burden, C. Hindley and A. Ebringer. Scandinavian Journal of Rheumatology, 1982; 11: 171 - 176.
. 18. An investigation into the properties of the Klebsiella strains isolated from ankylosing spondylitis patients. P.E. Pease, R.A. Tyler, J.R. England, D. Colthorpe and A. Ebringer.
Journal of Hygiene, 1982; 89: 119 - 123.
. 19. Properties of Yersinia enterocolitica strains isolated from ankylosing spondylitis patients. P. E. Pease, S.E. Palmer, R.L.Bartlett, D. Colthorpe, A. Ebringer and R. Ebringer. European Journal of Clinical Microbiology, 1982; 1: 256 - 257.
. 20. Muscle changes in ankylosing spondylitis. G.O. Hopkins, J. McDougald, K. Mills, D. Isenberg and A. Ebringer. British Journal of Rheumatology, 1983; 22: 151 - 157. (Espondilitisa daukaten gaixoen giharrek nozitzen dituzten aldaketez lehenbizikoz plazaratutako idatzia)
. 21. The crosstolerance hypothesis, HLA-B27 and ankylosing spondylitis. A. Ebringer. British Journal of Rheumatology 1983; 22 (suppl.2): 53 - 66.
. 21-b. La Spondylarthrite ankylosante, HLA B27 et la théorie de la tolérance croisée. A. Ebringer. Revue du Rhumatisme, 1983; 50 (11): 763 - 769.
. 22. Circulating immune complexes in ankylosing spondylitis. H. Deicher, A. Ebringer, S. Hildebrand, A. Kemper and H. Zeidler. British Journal of Rheumatology, 1983; 22(suppl.2): 122 - 127.
. 23. IgA antibodies in ankylosing spondylitis. A.K. Trull, R. Ebringer, G.S. Panayi, D. Colthorpe, A. Ebringer and D.C.O. James. Scandinavian Journal of Rheumatology, 1983; 12: 249 - 253. (Espondilitisa daukaten gaixoek Klebsiellaren kontrako antigorputzak kopuru handitan dauzkatela lehenbizikoz plazaratu zuen idatzia)
. 24. La spondylarthrite ankylosante, HLA-B27 et la theorie de la tolerance croisee. A. Ebringer. Revue du Rhumatisme, 1983; 50: 763 - 769.
. 25. HLA-B27 and the immune response to enterobacterial antigens in ankylosing spondylitis.
A.K. Trull, A. Ebringer, G.S. Panayi, R. Ebringer and D.C.O. James. Clinical and Experimental Immunology, 1984; 55: 74 - 80.
. 26. Etiopathogenesis of ankylosing spondylitis and the crosstolerance hypothesis. A. Ebringer, M. Baines, M. Childerstone, M. Ghuloom and T. Ptaszynska. "The spondyloarthropathies." Edited by M. Ziff and S.B. Cohen. Raven Press New York, 1985. Advances in Inflammation Research, 1985; 9: 101 - 128. (Almidoi Gutxiko Errejimena erabili duten gaixo espondilitisdunei buruzko lehenbiziko idatzia)
. 27. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella. A. Ebringer, M. Baines, T. Ptaszynska. Immunological Review, 1985; 86: 103 - 118.
. 28. Antibodies to Proteus in Rheumatoid arthritis. A. Ebringer, T. Ptaszynska, M. Corbett, C. Wilson, Y. Macafee, H. Avakian, P. Baron and D.C.O. James. Lancet, 1985; ii: 305 - 307. (Idatzi honetan lehenzibikoz erakusten da Artritis Reumatoideoa daukaten gaixoek Proteus-aren kontrako antigorputzak ugari dauzkatela, eta aldiz, Espondilitis Ankilopoietikoa daukatenek Klebsiellaren kontrako antigorputzak dauzkatela kopuru handitan).
. 29. Absence of antibodies to Yersinia enterocolitica in patients with ankylosing spondylitis in London. A.Toivanen, T.H. Stahlberg, K. Granfors and A. Ebringer. Lancet, 1986; ii: 1400.
. 30. Role of micro-organisms in the pathogenesis of HLA-B27 diseases. A. Ebringer, M. Ghuloom, T. Ptszynska and C Wilson. In: " Spondyloarthropathies - Involvement of the gut" Ed. E. Veys and H. Mielants. Excerpta Medica, Elsevier Amsterdam. 1987; Pg 235 - 247.
. 31. A study of anti-polynucleotide antibodies, anti-Klebsiella (K 30) antibodies and anti-DNA antibody idiotypes in ankylosing spondylitis D. Isenberg, R. Feldman, C. Dudeney, F. Konikoff, D. Jones, A. Ebringer and Y. Schoenfeld. British Journal of Rheumatology, 1987; 26: 168 - 171.
. 32. Klebsiella antibodies in ankylosing spondylitis and Proteus antibodies in rheumatoid arthritis.
A. Ebringer, N. Cox, I Abuljadayel, M. Ghuloom, S. Khalafpour, T. Ptaszynska, F. Shodjai-Moradi and C Wilson. British Journal of Rheumatology, 1988; 27 (suppl. 2): 72 - 85.
. 33. Antibodies to Klebsiella and Proteus microorganisms in ankylosing spondylitis and rheumatoid arthritis measured by ELISA. S. Khalafpour, A. Ebringer, I. Abuljadayel and M. Corbett.
British Journal of Rheumatology, 1988; 27 (suppl 2): 86 - 89.
. 34. Ankylosing spondylitis and Klebsiella reactive arthritis. A. Ebringer. Journal of Orthopaedic Rheumatology, 1988; 1: 243 - 250.
. 35. The relation between Klebsiella infection and ankylosing spondylitis. A. Ebringer. In Balliere`s "Clinical Rheumatology": "The gut and rheumatic disease". Ed. By P.J.Rooney, 1989 (August); 3: 321 - 338.
. 36. The use of enzyme immunoassay (EIA) and radiobinding assay to investigate the crossreactivity of Klebsiella antigens and HLA-B27 in ankylosing spondylitis patients and healthy controls. M.G, Baines, A. Ebringer, H, Avakian, H. Samuel and D.C.O. James. Scandinavian Journal of Rheumatology, 1990; 19: 341 - 349.
. 37. Theoretical models to explain the association of HLA-B27 with ankylosing spondylitis. A. Ebringer. Scandinavian Journal of Rheumatology. 1990; suppl.87: 151 -163.
. 38. Ankylosing spondylitis and Klebsiella - the debate continues. A. Ebringer. The Journal of Rheumatology 1991; 18: 312 -313.
. 39. Ankylosing spondylitis is caused by Klebsiella: Evidence from immunogenetic, microbiologic and serologic studies. (Testu OSOA). A. Ebringer. Rheumatic Disease Clinics of North America 1992; 18: 105 - 121.
. 40. Molecular Mimicry. A. Ebringer. In "Encyclopedia of Immunology" Eds. I. Roitt and P.J. Delves.
W.B. Saunders: London 1992 Pgs:1084 - 1086.
. 41. IgA antibody response to Klebsiella in ankylosing spondylitis measured by immunoblotting.
F. Shodjai-Moradi, A. Ebringer and I. Abuljadayel. Annals of Rheumatic Diseases 1992; 51: 151 - 163.
. 42. Ankylosing spondylitis and HLA-B27: Restriction fragment length polymorphism and sequencing of an HLA-B27 allele from an ankylosing spondylitis patient. C.M. Higgins T. Lund, M.E. Shipley, A. Ebringer, M. Sadowska-Wroblewska and R.K. Craig. Annals of Rheumatic Diseases 1992; 51: 855 - 862.
. 43. HLA and disease. M. Baines and A. Ebringer. Molecular aspects of Medicine 1992; 13: 263 - 378.
- 44. Serum IgA anti-Klebsiella antibodies in ankylosing spondylitis patients from Catalonia. A. Collado, J. Gratacos, A. Ebringer, T. Rashid, A. Marti and J. Munoz-Gomez. Scandinavian Journal of Rheumatology 1994; 23: 119 - 123.
. 45. Que va-t-il-se passer demain en ce qui concerne HLA-B27 et la spondylarthrite ankylosante?
A. Ebringer. Annales de Medicine Interne 1994; 145: 238 - 240 (Interview du mois).
. 46. Molecular mimicry and ankylosing spondylitis: possible role of a novel sequence in pullulanase of Klebsiella pneumoniae. (Testu OSOA). (Kickasen).
. 47. Molecular mimicry: The geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy. (Testu OSOA). (T. Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H and Wilson C. Clinical Rheumatology 1996; 15: Suppl 1, 57 - 61.
. 48. The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis (Testu OSOA). Ebringer A, Wilson C. Clinical Rheumatology 1996; 15: suppl 1, 62 - 66.
. 49. Antibodies to Klebsiella, Proteus and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis. (Testu OSOA). (oTani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, Bansal S and Ebringer A. Journal of Rheumatology 1997; 24: 109 - 114.
. 50. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn`s disease and ulcerative colitis. Tiwana H, Wilson C, Walmsley RS, Wakefield AJ, Smith MNS, Cox NL, Hudson MJ and Ebringer A. Rheumatology International 1997; 17: 11 - 16.
. 51. Antibodies to Klebsiella pneumoniae in Dutch patients with ankylosing spondylitis and acute anterior uveitis and to Proteus mirabilis in rheumatoid arthritis. Blankenberg-Sprenkels S, Fielder M, Feltkamp TEW, Tiwana H, Wilson C and Ebringer A. Journal of Rheumatology 1998; 25: 743 - 747.
. 52. Molecular mimicry. Ebringer A. In "Encyclopedia of Immunology - second edition"
Eds. IM Roitt and PJ Delves. Academic Press: London 1998 (pages 1736 - 1742).
. 53. Antibodies to Klebsiella pneumoniae nitrogenase reductase in patients with ankylosing spondylitis. Ahmadi K, Wilson C, Tiwana H, Shanmuganathan S, BinderA and Ebringer A. Annals of Rheumatic Diseases 1998; 57: 441.
. 54. Antibodies to Klebsiella pneumoniae lipoposaccharide in patients with ankylosing spondylitis.
Ahmadi K, Wilson C, Tiwana H, Binder A and Ebringer A. British Journal of Rheumatology 1998; 37: 1330 - 1333.
. 55. Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Tiwana H, Walmsley RS, Wilson C, Yiannakou JY, Ciclitira PJ, Wakefield AJ and Ebringer A. British Journal of Rheumatology 1998; 37: 525 - 531.
. 56. HLA molecules, bacteria and autoimmunity. Ebringer A and Wilson C. Journal of Medical Microbiology 2000; 49: 305 - 311.
. 57. Ankylosing spondylitis and diet. Ebringer A and Wilson C. In: "Food allergy and intolerance." Edited by Brostoff J and Challacombe C. 2002; 55: 761 - 768.
. 58. Correlation between the immune responses to collagen types I, III, IV, V and Klebsiella pneumoniae in patients with Crohn`s disease and ankylosing spondylitis. Tiwana H, Natt RS, Benitez-Brito R, Shah S, Wilson C, Bridger S, Harbord M, Sarner M and Ebringer A. Rheumatology; 2000 ( Accepted for Publication ).
. 59. Cytotoxicity responses to peptide antigens in Rheumatoid Arthritis and Ankylosing Spondylitis. Clyde Wilson, Taha Rashid, Harmale Tiwana, Huryia Beyan, Lucy Hughes, Sukvinder Bansal, Alan Ebringer and Allen Binder. Journal of Rheumatology 2003; 30:5 972 - 978
. 60. Ankylosing Spondylitis, HLS B27 and Klebsiella - An Overview: Proposal for early diagnosis and Treatment (OSORIK. PDF formatuan; irakur daiteke Word formatuan ere). Current Rheumatology Reviews 2006, 2: 55-68. Alan Ebringer, Taha Rashid, Clyde Wilson, Teresa Ptaszynska and Mark Fielder.
. 61. "B27 Disease" is a new autoimmune disease that affects millions of people. A. Ebringer and T. Rashid. Ann. of the New York Academy of Sciences. XXXX: 1 -9 (2007).
. 62. Ankylosing spondylitis is linked to Klebsiella - The evidence. Taha Rashid, Alan Ebringer. Clin. Rheumatol. 2007; 26: 858 - 864.

II. Artritis Erreumatoideaz.
. 63. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and Proteus mirabilis in rheumatoid arthritis. C Wilson, A Ebringer, K Ahmadi, J. Wrigglesworth, H Tiwana, M Fielder, A Binder, C Ettelaie, P Cunningham, C Joannou, S Bansal. Annals of the Rheumatic Diseases 1995; 54: 216 - 220.
. 64. The specificity of the anti-Proteus antibody response in tissue-typed Rheumatoid arthritis (RA) patients from Brest. M Fielder, H Tiwana, P Youinou, P Le Goff, R Deonarain, C Wilson, A Ebringer. Rheumatol Int. 1995; 15: 79 - 82.
. 65. Proteus IgG antibodies and C-Reactive Protein in English, Norwegian and Spanish patients with Rheumatoid arthritis. T. Rashid, G. Darlington, J. Kjeldsen-Kragh, A. Collado and A. Ebringer. Clinical Rheumatology 1999; 18: 190 - 195.
. 66. Rheumatoid arthritis: proposal for the use of anti-microbial therapy in early cases. Alan Ebringer, Taha Rashid, Clyde Wilson. Scandinavian Journal of Rheumatology 2003; 32: 2 - 11.
. 67. Rheumatoid arthritis is linked to Proteus - The evidence. Clinical Rheumatology 2007; 26: 1036 - 1043.

III. Crohn gaixotasunaz
. 68. Characterization of the humoral immune response to Klebsiella species in Inflamatory Bowel Disease and Ankylosing Spondylitis. H. Tiwana, R. S. Walmsley, C. Wilson, J. Y. Yiannakou, P.J. Ciclitira, A. J. Wakefield and A. Ebringer. British Journal of Rheumatology 1998; 37: 525 - 531.
. 69. Correlation between the immune responses to collagens type I, III and V and Klebsiella pneumoniae in patients with Crohn's disease and ankylosing spondylitis. H. Tiwana, R. S. Natt, R. Benitez-Brito, S. Shah, C. Wilson, S. Bridger, M. Harbord, M. Sarner and A. Ebringer. Rheumatology 2001; 40: 15 - 23.
. 70. A possible link between Crohn's disease and Ankilosing spondylitis via Klebsiella infections. Alan Ebringer, Taha Rashid, Harmale Tiwana, Clyde Silson. Clinical Rheumatology 2007; 26: 289 - 297.

IV.- Behien Entzefalopatia Espongiformeaz, Esklerosis Anizkoitzaz eta Scrapiez
. 71 Bovine Spongiform Encephalopathy: Is it an autoimmune disease due to bacteria showing molecular mimicry with brain antigens? Alan Ebringer, John Pirt, Clyde Wilson, Phil Cunningham, Carlos Thorpe and Camille Ettelaie. Environment Health Perspectives. 1997; 105: 1172 - 1174.
. 72 Bovine Spongiform Encephalopathy: comparison between the "prion" hypothesis and the autoimmune theory. A. Ebringer, J. Pirt, C. Wilson, C. Thorpe, H Tiwana, P. Cunningham and C. Ettelaie. Journal of Nutritional & Environmental Medicine 1998; 8: 265 - 276.
. 73. Autoantibodies to brain components and antibodies to Acinetobacter calcoaceticus are present in Bovine Spongiform Encephalopathy. Harmale Tiwana, Clyde Wilson, John Pirt, William Cartmell and Alan Ebringer. Infection and Immunity Dec. 1999; 6591 - 6595.
. 74. Molecular mimicry, mad cows and arthritis: Is bovine spongiform disease due to bacteria? Ebringer A. Science Spectra 2000; Issue 19: 46 - 53.
. 75. Antibody responses to Acinetobacter spp. and Pseudomonas aeruginosa in Multiple Sclerosis: prospects for diagnosis using the myelin-Acinetobacter-neurofilament antibody index. L. E. Hughes, S. Bonell, R. S. Natt, C. Wilson, H. Tiwana, A. Ebringer, P. Cunningham, V. Chamoun, E.J. Thompson, J. Croker and J. Vowles. Clinical and Diagnostic Laboratory Immunology Nov. 2001; 1181 - 1188.
. 76. Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in Bovine Spongiform Encephalopathy (BSE) in an attempt to develop and ante-mortem test. C. Wilson, L. E. Hughes, T. Rashid, A. Ebringer and S. Bansal. Journal of Clin. Lab. Immunol. 2003; 52: 023 - 040.
. 77. Cross-reactivity between related sequences found in Acinetobacter sp., Pseudomonas aeruginosa, myelin basic protein and myelin oligodendrocyte glycoprotein in multiple sclerosis. L. E. Hughes, P.A. Smith, S. Bonell, R.S. Natt, C. Wilson, T. Rashid, S. Amor, E.J. Thompson, J. Croker, A. Ebringer. Journal or Neuroimmunology. 2003; 144: 105 - 115.
. 78. Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy. C. Wilson, L. Hughes, T. Rashid, P. Cunningham, S. Bansal, A. Ebringer, C. Ettelaie. Veterinary Immunology and Immunopathology. 2004; 98: 1 - 7.
. 79. A possible link beween multiple sclerosis and Crutzfeldt-Jakob disease based on clinical, genetic, pathological and immunological evidence involving Acinetobacter bacteria. Alan Ebringer, Taha Rashid, Clyde Wilson, Richard Boden, Edward Thompson. Medical Hypotheses 2005; 64: 487 - 494.
. 80. Bovine Spongiform Encephalopathy, Multiple Sclerosis, and Creutzfeldt-Jakob Disease are probably autoimmune diseases evoked by Acinetobacter bacteria. Alan Ebringer, Taha Rashid and Clyde Wilson. Annals of the New York Academy of Sciences. 2005; 1050:417 - 426.
. 81. From rabies to transmissible spongiform encephalopathies: An immune-mediated microbial trigger involving molecular mimicry could be the answer. Alan Ebringer, Taha Rashid, Noor Jawad, Clyde Wilson, Edward J Thompson, Camille Ettelaie. Medical Hypotheses 2007; 68: 113 - 124.